Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111777520B reveals a safe, high-yield synthesis route for dimethylamino phenyl acetic acid intermediates, offering significant cost and safety advantages.
Patent CN112321535B reveals a novel ketone-based route for Imaric Acid, offering high purity and cost reduction for Imatinib manufacturing supply chains.
Novel four-step synthesis of PARP1 inhibitor intermediate via nitration and oxidative deamination. Offers high purity and scalable route for pharmaceutical manufacturing.
Patent CN102241614B details a phosphotungstic acid catalyzed method for N-alkyl amides offering significant supply chain stability and cost reduction advantages.
Novel patent CN107629014A offers mild conditions for triazole intermediate production ensuring supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Patent CN101891794B details a novel ursolic acid piperazine derivative with superior antitumor activity. Discover scalable synthesis routes and cost-effective manufacturing strategies.
Novel patent CN121342695A offers scalable chiral amino acid synthesis. Reduces waste and cost for IL-17 inhibitor intermediates. Reliable supply chain partner.
Discover the novel two-step synthesis of polysubstituted tetrahydrofuran dienoids from patent CN112142694A. Achieve cost reduction in pharmaceutical intermediate manufacturing with high yields.
Novel preparation of cis-2-(diphenylphosphino)-1-cyclohexanecarboxylic acid via asymmetric addition. Enhances catalytic efficiency and reduces manufacturing costs for high-purity intermediates.
Patent CN109734653B details a superior chiral resolution method for Argatroban precursors using L-dibenzoyltartaric acid, offering enhanced purity and cost-effective manufacturing scalability.
Discover the novel photocatalytic decarboxylative coupling method from patent CN108912042B. Enables mild, scalable production of high-purity aryl ketones for pharma.
Patent CN1209336C details a regioselective Pd-catalyzed halogenation process offering significant cost reduction and safety improvements for pharmaceutical intermediate manufacturing.
Patent CN114411180B reveals a green electrochemical method for constructing thio(seleno)phosphoric acid esters, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced synthesis of 2-methoxy-4-methylbenzylamine via safe reductive amination. Offers significant cost reduction in fine chemical manufacturing and high purity.
Patent CN114940964B reveals efficient UDCA production. Reduced costs and high purity for pharmaceutical supply chains.
Novel low-cost synthesis of 2-O-(3-aminopropyl hydrogen phosphoryl)-ascorbic acid via phosphorylation. High purity, scalable process for skincare actives.
Advanced synthesis of 2-chloro-5-thiophenecarboxylic acid via chlorination and oxidation. High-yield route for Razaxaban intermediates with reduced environmental impact.
Patent CN102993065B details a novel Lewis acid-catalyzed route for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Novel one-pot synthesis of naphthoquinone derivatives for anticancer and fluorescent applications. Efficient catalytic route reduces steps and cost.
Patent CN102249900B reveals novel esterification separation for adamantane isomers. Enhances purity and reduces waste for pharmaceutical intermediate supply chains.